As of the latest Form 4 filed Jun 24, 2026.
What Aquestive Therapeutics Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 29 most recent filings for AQST.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-24 | 2026-06-23 | Krop Julie Director | SSale | −25.0K | $5.02 | $125K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-23 | Krop Julie, Director | MExercise | +25.0K | $0.71 | $17.8K | Yes (planned) | Form 4 ↗ |
| 2026-06-16 | 2026-06-15 | Barber Daniel President and CEO | SSale | −25.0K | $4.16 | $104K | Yes (planned) | Form 4 ↗ |
| 2026-06-09 | 2026-06-08 | Korczynski Sherry Chief Commercial Officer | FTax | −2.71K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | Zalewski Thomas A. Chief Legal Officer | AAward | +100K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-15 | Barber Daniel President and CEO | SSale | −8.26K | $4.29 | $35.4K | Yes (planned) | Form 4 ↗ |
| 2026-05-18 | 2026-05-15 | Cioffi Melina SVP, Regulatory Affairs | FTax | −1.67K | $4.17 | $6.95K | No | Form 4 ↗ |
| 2026-05-11 | 2026-05-07 | BRAENDER LORI J Corporate Secretary | FTax | −136K | $4.23 | $574K | No | Form 4 ↗ |
| 2026-05-07 | 2026-05-05 | Boyd Peter E. Chief People Officer | FTax | −56.8K | $4.18 | $237K | No | Form 4 ↗ |
| 2026-05-07 | 2026-05-05 | Barber Daniel President and CEO | FTax | −336K | $4.18 | $1.40M | No | Form 4 ↗ |
| 2026-05-07 | 2026-05-05 | TOTH A ERNEST JR Chief Financial Officer | FTax | −92.7K | $4.18 | $387K | No | Form 4 ↗ |
| 2026-05-07 | 2026-05-05 | Jung Cassie Chief Operating Officer | FTax | −72.7K | $4.18 | $304K | No | Form 4 ↗ |
| 2026-05-07 | 2026-05-05 | BRAENDER LORI J Corporate Secretary | FTax | −76.1K | $4.18 | $318K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Boyd Peter E. Chief People Officer | SSale | −29.8K | $4.17 | $124K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Barber Daniel President and CEO | SSale | −181K | $4.17 | $754K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | BRAENDER LORI J Chief Legal Officer | SSale | −40.1K | $4.17 | $167K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Cioffi Melina SVP, Regulatory Affairs | SSale | −25.3K | $4.17 | $106K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | TOTH A ERNEST JR Chief Financial Officer | SSale | −58.3K | $4.17 | $243K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Korczynski Sherry Chief Commercial Officer | SSale | −15.7K | $4.17 | $65.7K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-10 | Jung Cassie Chief Operating Officer | SSale | −45.8K | $4.17 | $191K | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Boyd Peter E. Chief People Officer | AAward | +80.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Barber Daniel President and CEO | AAward | +262K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | BRAENDER LORI J Chief Legal Officer | AAward | +80.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Cioffi Melina SVP, Regulatory Affairs | AAward | +100K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | TOTH A ERNEST JR Chief Financial Officer | AAward | +95.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Korczynski Sherry Chief Commercial Officer | AAward | +75.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Jung Cassie Chief Operating Officer | AAward | +80.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Davis Matthew W. Chief Development Officer | AAward | +50.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-11 | 2026-03-09 | Greenhawt Matthew J. Chief Medical Officer | AAward | +75.0K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also AQST’s full analysis or the market-wide insider trading feed. The tabs above jump to AQST’s other SEC data.
Source: SEC Form 4 filings for AQST, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.